LifeSci Advisors

aTyr Pharma $LIFE Announces $20 Million Common Stock Purchase Agreement with Aspire Capital Fund, LLC https://www.lifesciadvisors.com/news/

Cidara Therapeutics $CDTX to Present New Clinical and Preclinical Data for Rezafungin and Influenza AVCs at IDWeek 2020 https://www.lifesciadvisors.com/news/

MiMedx $MDXG Launches EpiCord Expandable Placental Allograft as Addition to Market Leading Portfolio https://www.lifesciadvisors.com/news/

VYNE Therapeutics $VYNE Announces the Appointment of Patrick G. LePore to its Board of Directors https://www.lifesciadvisors.com/news/

Bionano Genomics $BNGO Expands Its Diagnostic Testing Menu with Launch of Lineagen’s EpiPanelDx PLUS Gene Panel Test that Identifies Genetic Conditions Related to Epilepsy https://www.lifesciadvisors.com/news/

Avadel Pharmaceuticals $AVDL Announces FT218 Leadership Transition https://www.lifesciadvisors.com/news/

Actinium Pharmaceuticals $ATNM Announces Successful Completion of Planned Phase 1 Actimab-A CLAG-M Combination Trial in Patients with Relapsed/Refractory AML at Medical College of Wisconsin https://www.lifesciadvisors.com/news/

Celyad Oncology $CYAD Establishes At-the-Market Facility https://www.lifesciadvisors.com/news/

Cellectar Reports Data on CLR 131 Phase 2 CLOVER-1 Study in Triple Class Refractory Multiple Myeloma Patients https://www.globenewswire.com//Cellectar-Reports-Data-on-C

Menlo Therapeutics $MNLO changes name to VYNE Therapeutics $VYNE. CEO and CFO buy 115,000 shares of common stock. Learn more here: https://bit.ly/2ZlGeVn and https://bit.ly/3m40Nix

A drug derived from the blood plasma of recovered Covid-19 patients is set to be tested as a preventive measure https://www.wsj.com//drug-derived-from-plasma-of-covid-19- via @WSJ

Enclosed spaces with clusters of people sharing food, talking loudlyand drinking alcoholall raise the risks of Covid-19 transmission https://www.wsj.com//what-makes-bars-and-restaurants-poten via @WSJ